Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-rosiglitazone
2. 163860-16-0
3. Rosiglitazone, (r)-
4. Rosiglitazone, (+)-
5. Sb 210232
6. 3u8pbh2bon
7. Chebi:50123
8. Sb-210232
9. (5r)-5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione
10. (5r)-5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
11. (5r)-5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
12. 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, (5r)-
13. 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, (r)-
14. Unii-3u8pbh2bon
15. Chembl333304
16. Schembl11957687
17. Zinc968330
18. (r)-brl-49653
19. Q27121917
| Molecular Weight | 357.4 g/mol |
|---|---|
| Molecular Formula | C18H19N3O3S |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 357.11471265 g/mol |
| Monoisotopic Mass | 357.11471265 g/mol |
| Topological Polar Surface Area | 96.8 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 469 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Sb 210232 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sb 210232, including repackagers and relabelers. The FDA regulates Sb 210232 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sb 210232 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sb 210232 supplier is an individual or a company that provides Sb 210232 active pharmaceutical ingredient (API) or Sb 210232 finished formulations upon request. The Sb 210232 suppliers may include Sb 210232 API manufacturers, exporters, distributors and traders.
click here to find a list of Sb 210232 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sb 210232 DMF (Drug Master File) is a document detailing the whole manufacturing process of Sb 210232 active pharmaceutical ingredient (API) in detail. Different forms of Sb 210232 DMFs exist exist since differing nations have different regulations, such as Sb 210232 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sb 210232 DMF submitted to regulatory agencies in the US is known as a USDMF. Sb 210232 USDMF includes data on Sb 210232's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sb 210232 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sb 210232 suppliers with USDMF on PharmaCompass.
Sb 210232 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sb 210232 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sb 210232 GMP manufacturer or Sb 210232 GMP API supplier for your needs.
A Sb 210232 CoA (Certificate of Analysis) is a formal document that attests to Sb 210232's compliance with Sb 210232 specifications and serves as a tool for batch-level quality control.
Sb 210232 CoA mostly includes findings from lab analyses of a specific batch. For each Sb 210232 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sb 210232 may be tested according to a variety of international standards, such as European Pharmacopoeia (Sb 210232 EP), Sb 210232 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sb 210232 USP).
LOOKING FOR A SUPPLIER?
